Ziad H Younes (Ziad Younes)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Hepatitis C Virus

Top Venues

Hepatology communications

Journal of medical virology

This page only lists publications with an associated author ORCID identifier.

Publications

Sven M Francque, Alexander Hodge, Jérôme Boursier, Ziad H Younes, Gerardo Rodriguez-Araujo, Grace S Park, Naim Alkhouri, Manal F Abdelmalek
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (2) (2024)
Sven M Francque, Alexander Hodge, Jérôme Boursier, Ziad H Younes, Gerardo Rodriguez-Araujo, Grace S Park, Naim Alkhouri, Manal F Abdelmalek
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (2) (2024)
Sven M Francque, Alexander Hodge, Jérôme Boursier, Ziad H Younes, Gerardo Rodriguez-Araujo, Grace S Park, Naim Alkhouri, Manal F Abdelmalek
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (2) (2024)
Sven M Francque, Alexander Hodge, Jérôme Boursier, Ziad H Younes, Gerardo Rodriguez-Araujo, Grace S Park, Naim Alkhouri, Manal F Abdelmalek
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (2) (2024)
Fred Poordad, Michael Bennett, Thomas E Sepe, Eric Cohen, Robert W Reindollar, Gregory Everson, Raymond W Phillips, Asma Siddique, J Greg Sullivan, Tami Pilot-Matias, Manal Abunimeh, Daniel E Cohen, Ziad H Younes
Ombitasvir/paritaprevir/ritonavir and dasabuvir with or without sofosbuvir for patients with hepatitis C virus genotype 1 infection who failed a prior course of direct-acting antiviral therapy. Journal of medical virology 91 (7) (2019)